Director Varon Leslie F buys 9,337 shares of XRAY at $10.71 (+19.4% to holdings) despite -427.0M net loss and -4.3% revenue decline.
Director Varon Leslie F purchased 9,337 shares at $10.71 for a total value of $99,999.27, increasing his holdings by 19.4% from 48,005 to 57,342 shares. The purchase occurs in a context of material corporate stress: the company reported a net loss of $-427.0M in its most recent fiscal year and annual revenue contraction of -4.3%, with the stock trading at -45.4% from its 52-week high of $20.31. The timing relative to price momentum is notable: the stock has declined -15.4% over 30 days and -22.6% over 90 days, and currently trades at $11.09, only 3.5% above the transaction price. This is a discretionary open-market purchase by a director accumulating more than 9,000 shares into a company facing both operational headwinds and significant equity value destruction.